HomeCompareMEDXF vs KO

MEDXF vs KO: Dividend Comparison 2026

MEDXF yields 89.29% · KO yields 2.71%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MEDXF wins by $2.45M in total portfolio value
10 years
MEDXF
MEDXF
● Live price
89.29%
Share price
$2.24
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.49M
Annual income
$776,963.67
Full MEDXF calculator →
KO
The Coca-Cola Company
● Live price
2.71%
Share price
$76.05
Annual div
$2.06
5Y div CAGR
24.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.1K
Annual income
$4,323.37
Full KO calculator →

Portfolio growth — MEDXF vs KO

📍 MEDXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEDXFKO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEDXF + KO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MEDXF pays
KO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDXF
Annual income on $10K today (after 15% tax)
$7,589.29/yr
After 10yr DRIP, annual income (after tax)
$660,419.12/yr
KO
Annual income on $10K today (after 15% tax)
$230.24/yr
After 10yr DRIP, annual income (after tax)
$3,674.86/yr
At 15% tax rate, MEDXF beats the other by $656,744.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDXF + KO for your $10,000?

MEDXF: 50%KO: 50%
100% KO50/50100% MEDXF
Portfolio after 10yr
$1.26M
Annual income
$390,643.52/yr
Blended yield
30.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KO right now

MEDXF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
0.9
Piotroski
5/9
KO
Analyst Ratings
29
Buy
16
Hold
3
Sell
Consensus: Buy
Price Target
$84.88
+11.6% upside vs current
Range: $81.00 — $88.00
Altman Z
5.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDXF buys
0
KO buys
0
No recent congressional trades found for MEDXF or KO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEDXFKO
Forward yield89.29%2.71%
Annual dividend / share$2.00$2.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%24.3%
Portfolio after 10y$2.49M$34.1K
Annual income after 10y$776,963.67$4,323.37
Total dividends collected$2.19M$15.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy

Year-by-year: MEDXF vs KO ($10,000, DRIP)

YearMEDXF PortfolioMEDXF Income/yrKO PortfolioKO Income/yrGap
1← crossover$19,629$8,928.57$10,847$336.70+$8.8KMEDXF
2$37,382$16,378.98$11,832$431.92+$25.6KMEDXF
3$69,150$29,152.23$12,992$557.22+$56.2KMEDXF
4$124,390$50,399.46$14,379$723.66+$110.0KMEDXF
5$217,827$84,729.38$16,059$947.18+$201.8KMEDXF
6$371,743$138,667.67$18,129$1,251.14+$353.6KMEDXF
7$618,933$221,167.77$20,724$1,670.45+$598.2KMEDXF
8$1,006,401$344,142.93$24,040$2,258.40+$982.4KMEDXF
9$1,599,826$522,977.14$28,364$3,098.25+$1.57MMEDXF
10$2,488,777$776,963.67$34,134$4,323.37+$2.45MMEDXF

MEDXF vs KO: Complete Analysis 2026

MEDXFStock

Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. It focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, and allergy. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, a prescription allergy medication. Its products portfolio also includes Treosulfan, a bifunctional alkylating agent for allogeneic hematopoietic stem cell transplantation; Trispan, a triamcinolone hexacetonide injectable suspension; and Gleolan, an optical imaging agent indicates for patients with glioma symptoms. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Bolton, Canada.

Full MEDXF Calculator →

KOConsumer Staples

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Full KO Calculator →
📬

Get this MEDXF vs KO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDXF vs SCHDMEDXF vs JEPIMEDXF vs OMEDXF vs MAINMEDXF vs PEPMEDXF vs PGMEDXF vs JNJMEDXF vs MCD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.